A summary as of June 1, 2020:
- Forty-eight poison pills have been adopted, up from 39 as of May 1.
- Four repricings have been undertaken, up from 1 as of May 1.
- 10.5 percent of Russell 3,000 companies can reprice options, up from 9.1 percent as of May 1.
- 3.9 percent of Russell 3,000 companies have active poison pills, up from 3.8 percent as of May 1.
By Mustafa Olomi, Senior Associate, ISS ESG
